Application of the da Vinci surgical robot system in presacral nerve sheath tumor treatment

Feifei Pu1, Zhicai Zhang1, Zhaohui Chen2

  • 1Department of Orthopedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R. China.

Oncology Letters
|September 16, 2020
PubMed

Insights

Da Vinci robotic surgery is a safe and effective treatment for presacral nerve sheath tumors. This minimally invasive approach resulted in complete tumor removal, rapid recovery, and short hospital stays for all patients.

Area of Science:

  • Surgical Oncology
  • Minimally Invasive Surgery
  • Robotic Surgery

Background:

  • Presacral tumors, particularly nerve sheath tumors, present unique surgical challenges.
  • Traditional surgical approaches may involve significant morbidity and prolonged recovery periods.

Purpose of the Study:

  • To evaluate the feasibility, efficacy, and safety of da Vinci robotic surgery for treating presacral tumors.
  • To assess surgical outcomes including tumor resection, patient recovery, and complication rates.

Main Methods:

  • A retrospective analysis of 12 patients with presacral nerve sheath tumors who underwent da Vinci robotic surgery between March 2016 and April 2019.
  • Data collected included tumor resection completeness, surgical duration, pain scores (Visual Analog Scale), blood loss, and postoperative recovery parameters.

Main Results:

  • Complete tumor resection was achieved in all 12 patients.
  • Mean surgical duration was 106.08 minutes with mean intraoperative blood loss of 101.67 ml.
  • Patients experienced significant pain reduction (VAS scores decreased from 3.25 preoperatively to 0.08 at 3 months postoperatively), early ambulation, and a short mean hospital stay of 3.92 days.
  • No major peri- or postoperative complications were reported.

Conclusions:

  • Da Vinci robotic surgery is a safe and effective option for presacral nerve sheath tumors.
  • The procedure offers advantages such as high safety, minimal bleeding, and accelerated patient recovery.
  • Further investigation into robotic-assisted surgery for these tumors is warranted.

Related Concept Videos